GetPortalImpactFactorByIdResp(projectId=1, id=d39212536, cover=https://img.medsci.cn/images/journal/cover/2021/BSb_202109271316440300.jpg, fullname=Translational Psychiatry, abbr=TRANSL PSYCHIAT, pyear=暂无数据, frequence=Monthly, articleNumbers=2838, citedSelf2015=3.9, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均3.5月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2158-3188, greenSci=https://www.greensci.net/search?kw=2158-3188, scijournal=https://www.scijournal.org/impact-factor-of-TRANSL-PSYCHIAT.shtml, medsciHotlightString=null, medsciHotlightRealtime=10.444, medsciHotlight=8.634, medsciHotlight5year=6.7105, citescore=8.5, hIndex=82, impactFactor=6.8, orgnization=Nature Publishing Group, orgnizationUrl=http://www.nature.com, country=United Kingdom, countryCn=英国, isOa=1, isOaString=是, sciScie=Science Citation Index Expanded|Current Contents - Clinical Medicine, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=http://www.nature.com/tp/index.html, websiteHits=5674, guideForAuthor=https://www.nature.com/tp/authors-and-referees, guideForAuthorHits=1212, submitWebsite=https://mts-tp.nature.com/cgi-bin/main.plex, submitWebsiteHits=3395, content=<p class="norm" style="color: #222222;">Psychiatry has been held back by our limited translational pipeline. Nobel laureate Julius Axelrod's discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of most commonly prescribed types of antidepressants treatment. Likewise, dopamine receptor antagonists are widely used to treat schizophrenia. Pierre Deniker and Jean Delay conducted a clinical trial at the Sainte-Anne Hospital Center in Paris in which they treated 38 psychotic patients with daily injections of chlorpromazine, a dopamine receptor antagonist, without the use of other sedating agents. The response was dramatic; treatment with chlorpromazine went beyond simple sedation with patients showing improvements in thinking and emotional behavior. That was first reported in 1952.</p> <p class="norm" style="color: #222222;">There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients that will result in better outcomes than what is provided by existing approaches. <em>Translational Psychiatry</em> bridges this gap by focusing on papers that directly study psychiatric disorders and bring new discovery into clinical practice. In addition to this core mission of the journal, we may consider papers from all areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging, and epidemiology, that have potential to contribute to enhance the field of translational psychiatry more broadly. To maintain balance, such papers that do not directly address our core mission will be considered on a case-by-case basis, as a matter of editorial discretion, which can also be supported by advice gained during the peer review process.</p> <h2 id="why-publish" style="color: #222222;">We are the <strong>highest-ranked open access journal in Psychiatry,</strong> with the aim of bridging the gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients.</h2> <p style="color: #222222;"><strong>Open access</strong> publication ensures that <strong>your article can be easily discovered, accessed, used, and shared, maximizing your impact </strong>and acting as a springboard for further discovery.<br /><br />We provide a <strong>clear and supportive publication process, </strong>and ensure <strong>high visibility</strong> for your publication through our nature.com platform.</p> <p style="color: #222222;">Our<strong> highly-respected editorial team</strong> leads a rigorous and rapid peer review process.</p> <h2 id="journal-metrics" style="color: #222222;">Journal metrics</h2> <p style="color: #222222;">The 2021 journal citation metrics for <em><em class="journalName">Translational Psychiatry</em> </em>are as follows:</p> <p style="color: #222222;">2-year Impact Factor* (2022): <strong>6.8</strong><br />5-year Impact Factor* (2022): <strong>7.0</strong><br />Immediacy index*: <strong>1.111</strong><br />Eigenfactor® score*: <strong>0.03067</strong><br />Article influence score*: <strong>2.171</strong><br />JCR Rank*: <strong>PSYCHIATRY 24/156</strong><br />Journal Citation Score*: <strong>1.7</strong><br /><br />SNIP: <strong>1.508</strong><br />SJR: <strong>2.652</strong></p> <p class="norm" style="color: #222222;">*2020 Journal Citation Reports^® Science Edition (Clarivate Analytics, 2021)</p> <ul style="color: #222222;"> <li class="norm">1,417,295 Downloads</li> </ul> <p class="norm" style="color: #222222;">Speed:<br />15 days to first decision for all manuscripts (Median)<br />50 days to first decision for reviewed manuscripts only (Median)<br /><br />Usage:<br />3,789,561 Downloads (in 2022)<br />10,415 Altmetric mentions (2021)</p> <h2 id="abstracted-indexed-in" style="color: #222222;">Abstracted/indexed in</h2> <p class="norm" style="color: #222222;">PubMed/MEDLINE<br />PubMed Central<br />Scopus<br />ISI Web of Science<br />DOAJ<br />British Library<br />Crossref</p> <h2 id="issn" style="color: #222222;">ISSN and E-ISSN</h2> <p class="norm" style="color: #222222;">The ISSN (online) number for <em>Translational Psychiatry</em> is 2158-3188.</p>, totalCites=19301, brief=TRANSL PSYCHIAT杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=精神病学" >精神病学</a></strong>”子行业的级别不明杂志, articleType=绝大部分收录论著，也接收少量其它类型文章, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=TRANSL PSYCHIAT 在该细分领域可能是国际一流杂志，但是国内关注少，可能与很难投中有关吧，可以试试，但不要报过高中的期望哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=d39212536'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=228, tagName=抑郁症, createdHits=3), ImpactFactorTagDto(id=1608, tagName=转化医学, createdHits=2), ImpactFactorTagDto(id=89103, tagName=精神类疾病, createdHits=2), ImpactFactorTagDto(id=6429, tagName=精神疾病, createdHits=1), ImpactFactorTagDto(id=18688, tagName=神经科学, createdHits=1), ImpactFactorTagDto(id=6429, tagName=精神疾病, createdHits=1), ImpactFactorTagDto(id=64, tagName=脑卒中, createdHits=1), ImpactFactorTagDto(id=66162, tagName=mental health, createdHits=1), ImpactFactorTagDto(id=487716, tagName=mentalhealth, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=4.38), GetImpactFactorCiteScoreListResponse(year=2017, citescore=4.86), GetImpactFactorCiteScoreListResponse(year=2018, citescore=5.54), GetImpactFactorCiteScoreListResponse(year=2019, citescore=8.8), GetImpactFactorCiteScoreListResponse(year=2020, citescore=8.5)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=6.996), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=8.234), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=10.132), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=8.93), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=10.444)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Psychiatry and Mental Health , rank=16/494), GetImpactFactorCiteScoreGradeResponse(smallClass=Neuroscience - Biological Psychiatry , rank=3/40), GetImpactFactorCiteScoreGradeResponse(smallClass=Neuroscience - Cellular and Molecular Neuroscience , rank=14/85)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=PSYCHIATRY, rank=Q1)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2158-3188[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=TRANSLATIONAL PSYCHIATRY[ta], article_number=530, article_number_cn=94, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)